Tumour necrosis factor alpha gene (TNF-α) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis

Journal of Neuroimmunology

Volumn 208, Issue 1-2, 2009, Pages 115-118

  Losonczi, Erika ^a   Bencsik, Krisztina ^a   Nagy, Zsanett Fricska ^a   Honti, Viktor ^b   Szalczer, Estilla ^a   Rajda, Cecília ^a   Illés, Zsolt ^c   Mátyás, Klotild ^d   Rózsa, Csilla ^e   Csépány, Tünde ^f   Füvesi, Judit ^a   Vécsei, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d 1st Department of Internal Medicine   (Hungary)

^e Jahn Hospital Budapest   (Hungary)

^f UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Multiple sclerosis (MS); Primary progressive multiple sclerosis (PPMS); Single nucleotide polymorphism (SNP); Tumour necrosis factor alpha (TNF )

Indexed keywords

GUANINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUNGARY; MALE; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADENINE; ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GUANINE; HUMANS; HUNGARY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62549101286     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.01.004     Document Type: Article

References (25)

1. Bayley J.P., de Rooij H., van den Elsen P.J., Huizinga T.W.J., and Verweij C.L. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 14 (2001) 316-323
2. Bencsik K., Rajda C., Füvesi J., Klivényi P., Járdánházy T., Török M., and Vécsei L. The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary. Eur. Neurol. 46 (2001) 206-209
3. Brinkman B.M.N., Huizinga T.W.J., Kurban S.S., van der Velde E.A., Schreuder G.M., Hazes J.M.W., Breedveld F.C., and Verweij C.L. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?. Br. J. Rheumatol. 36 (1997) 516-521
4. De Jong B.A., Huizinga T.W.J., Zanelli E., Giphart M.J., Bollen E.L.E.M., Uitdehaag B.M.J., Polman C.H., and Westendorp R.G.J. Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 59 (2002) 549-555
5. Drulović J., Popadić D., Mesaroš S., Dujmović I., Cvetković I., Miljković D., Stojsavljević N., Pravica V., Pekmezović T., Bogdanović G., Jarebinski M., and Stojković M.M. Decreased frequency of the tumor necrosis factor alpha -308 allele in Serbian patients with multiple sclerosis. Eur. Neurol. 50 (2003) 25-29
6. Fernandez-Arquero M., Arroyo R., Rubio A., Martin C., Vigi P., Conejero L., Figueredo M.A., and de la Concha E.G. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 53 (1999) 1361-1363
7. Fernandes Filho J.A.M., Vedeler C.A., Myhr K.M., Nyland H., and Pandey J.P. TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity 35 (2002) 377-380
8. He B., Navikas V., Lundahl J., Söderström M., and Hillert J. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J. Neuroimmunol. 63 (1995) 143-147
9. Huizinga T.W.J., Westendorp R.G.J., Bollen E.L.E.M., Keijsers V., Brinkman B.M.N., Langermans J.A.M., Breedveld F.C., Verweij C.L., van de Gaer L., Dams L., Crusius J.B.A., García-Gonzalez A., van Oosten B.W., Polman C.H., and Peňa A.S. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J. Neuroimmunol. 72 (1997) 149-153
10. Kamali-Sarvestani E., Nikseresht A., Aflaki E., Sarvari J., and Gharesi-Fard B. TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis. Acta Neurol. Scand. 115 (2007) 161-166
11. Knight J.C., Udalova I., Hill A.V.S., Greenwood B.M., Peshu N., Marsh K., and Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22 (1999) 145-150
12. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
13. Lassmann H., Brück W., and Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17 (2007) 210-218
14. Lucotte G., Bathelier C., and Mercier G. TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients. Mult. Scler. 6 (2000) 78-80
15. Maurer M., Kruse N., Giess R., Kyriallis K., Toyka K.V., and Rieckmann P. Gene polymorphism at position -308 of the tumor necrosis factor alpha promoter is not associated with disease progression in multiple sclerosis patients. J. Neurol. 246 (1999) 949-954
16. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
17. Mihailova S., Ivanova M., Mihaylova A., Quin L., Mikova O., and Naumova E. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J. Neuroimmunol. 168 (2005) 138-143
18. Mycko M., Kowalski W., Kwinkowski M., Buenafe A.C., Szymanska B., Tronczynska E., Plucienniczak A., and Selmaj K. Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J. Neuroimmunol. 84 (1998) 198-206
19. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., and Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 58 (2005) 840-846
20. Rieckmann P., Albrecht M., Kitze B., Weber T., Tumani H., Broocks A., Lüer W., Helwig A., and Poser S. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37 (1995) 82-88
21. Ristić S., Lovrecić L., Starcević-Cizmarević N., Brajenović-Milić B., Sega Jazbec S., Sepcić J., Kapović M., and Peterlin B. Tumor necrosis factor alpha -308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Eur. Neurol. 57 (2007) 203-207
22. Roxburgh R.H.S.R., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., Achiti I., Confavreux C., Coustans M., le Page E., Edan G., McDonnell G.V., Hawkins S., Trojano M., Liguori M., Cocco E., Marrosu M.G., Tesser F., Leone M.A., Weber A., Zipp F., Miterski B., Epplen J.T., Oturai A., Sørensen P.S., Celius E.G., Lara N.T., Montalban X., Villoslada P., Silva A.M., Marta M., Leite I., Dubois B., Rubio J., Butzkueven H., Kilpatrick T., Mycko M.P., Selmaj K.W., Rio M.E., Sá M., Salemi G., Savettieri G., Hillert J., and Compston D.A.S. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64 (2005) 1144-1151
23. Rudick R.A., and Ransohoff R.M. Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity. Arch. Neurol. 49 (1992) 265-270
24. Sharief M.K., and Hentges R. Association between tumor-necrosis-factor-alpha and disease progression in patients with multiple-sclerosis. N. Engl. J. Med. 325 (1991) 467-472
25. Wirz S.A., Morale M.C., Marchetti B., Barr A.M., Sotgiu S., Rosati G., Pugliatti M., Sanna M.V., Giliberto O., Bartfai T., and Conti B. High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia. Cytokine 26 (2004) 149-154